Sunitinib as salvage treatment including potent anti-tumor activity in carcinomatous ulcers for patients with multidrug-resistant metastatic breast cancer

OBJECTIVE: To evaluate the efficacy and safety of single-agent sunitinib as salvage treatment in Chinese patients with multidrug-resistant metastatic breast cancer (MBC). RESULTS: 37 patients were enrolled with median age of 48 years. 17 had hormone receptor (HR)-positive tumors, 7 had HER2-positive...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Bing, Zhao, Xin, Ding, Lijuan, Meng, Xiangying, Song, Santai, Wu, Shikai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295398/
https://www.ncbi.nlm.nih.gov/pubmed/27506945
http://dx.doi.org/10.18632/oncotarget.11082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295398/
https://www.ncbi.nlm.nih.gov/pubmed/27506945
http://dx.doi.org/10.18632/oncotarget.11082

Ejemplares similares